Spekhorst LS, Bakker D, Drylewicz J, Rispens T, et al. Patient-centered dupilumab dosing regimen leads to successful dose reduction in persistently controlled atopic dermatitis. Allergy 2022 Jul 15. doi: 10.1111/all.15439.
PMID: 35837880